OSTEONIC Co., Ltd. (KOSDAQ:226400)
4,205.00
+460.00 (12.28%)
At close: Jun 29, 2026
OSTEONIC Revenue
OSTEONIC had revenue of 12.90B KRW in the quarter ending March 31, 2026, with 35.39% growth. This brings the company's revenue in the last twelve months to 48.77B, up 35.20% year-over-year. In the year 2025, OSTEONIC had annual revenue of 45.39B with 32.59% growth.
Revenue (ttm)
48.77B
Revenue Growth
+35.20%
P/S Ratio
1.73
Revenue / Employee
237.88M
Employees
205
Market Cap
84.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.39B | 11.16B | 32.59% |
| Dec 31, 2024 | 34.23B | 6.44B | 23.15% |
| Dec 31, 2023 | 27.80B | 7.96B | 40.12% |
| Dec 31, 2022 | 19.84B | 4.24B | 27.19% |
| Dec 31, 2021 | 15.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 137.97B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 64.49B |
| CG MedTech | 48.51B |
| DuChemBIO | 39.82B |
| Wonbiogen | 36.27B |
| SCL Science | 27.40B |
| MEDYSSEY Co.,Ltd | 10.60B |